JNJ

192.81

+0.35%↑

ABT

127.86

+0.06%↑

MDT

95.84

-0.02%↓

VEEV

289.4

-0.16%↓

A

145.98

+0.05%↑

JNJ

192.81

+0.35%↑

ABT

127.86

+0.06%↑

MDT

95.84

-0.02%↓

VEEV

289.4

-0.16%↓

A

145.98

+0.05%↑

JNJ

192.81

+0.35%↑

ABT

127.86

+0.06%↑

MDT

95.84

-0.02%↓

VEEV

289.4

-0.16%↓

A

145.98

+0.05%↑

JNJ

192.81

+0.35%↑

ABT

127.86

+0.06%↑

MDT

95.84

-0.02%↓

VEEV

289.4

-0.16%↓

A

145.98

+0.05%↑

JNJ

192.81

+0.35%↑

ABT

127.86

+0.06%↑

MDT

95.84

-0.02%↓

VEEV

289.4

-0.16%↓

A

145.98

+0.05%↑

Vaxart Inc

Затворен

0.32

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Ключови измерители

By Trading Economics

Приходи

605K

-15M

Продажби

19M

40M

Марж на печалбата

-37.72

Служители

105

EBITDA

155K

-12M

Дивиденти

By Dow Jones

Следващи печалби

12.11.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-1.4M

81M

Предишно отваряне

0.32

Предишно затваряне

0.32

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

Vaxart Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

22.10.2025 г., 22:47 ч. UTC

Придобивния, сливания и поглъщания

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project -- Update

22.10.2025 г., 22:13 ч. UTC

Придобивния, сливания и поглъщания

Woodside Energy Signs Up Williams as Investor in Louisiana LNG Project

22.10.2025 г., 21:20 ч. UTC

Печалби

Correction to IBM 3Q Sales Jump Article

22.10.2025 г., 20:57 ч. UTC

Печалби

SAP Posts Higher 3Q Revenue, Operating Profit

22.10.2025 г., 23:46 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

22.10.2025 г., 23:46 ч. UTC

Пазарно говорене

Nikkei May Decline Amid U.S.-China Trade Tensions -- Market Talk

22.10.2025 г., 23:41 ч. UTC

Пазарно говорене

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22.10.2025 г., 23:38 ч. UTC

Пазарно говорене

Gold Extends Pullback on Likely Profit-Taking -- Market Talk

22.10.2025 г., 23:15 ч. UTC

Печалби

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 4th Update

22.10.2025 г., 22:28 ч. UTC

Пазарно говорене

Alcoa Cautions About Spending More on U.S. Smelters -- Market Talk

22.10.2025 г., 22:02 ч. UTC

Печалби

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 3rd Update

22.10.2025 г., 21:59 ч. UTC

Придобивния, сливания и поглъщания

Williams Cos.: Entered Into 1.5 Mtpa LNG Offtake Obligation >WMB

22.10.2025 г., 21:58 ч. UTC

Придобивния, сливания и поглъщания

Williams Cos. to Buy 10% Interest in Louisiana LNG LLC >WMB

22.10.2025 г., 21:57 ч. UTC

Придобивния, сливания и поглъщания

Williams Cos. to Buy 80% Ownership In, Become Operator of Driftwood Pipeline >WMB

22.10.2025 г., 21:56 ч. UTC

Придобивния, сливания и поглъщания

Williams Cos.: Strategic Partnership Entered With Woodside Energy to Invest in Louisiana LNG Project >WMB

22.10.2025 г., 21:47 ч. UTC

Придобивния, сливания и поглъщания

Woodside: Williams to Assume LNG Offtake Obligations for 10% of Produced Volumes

22.10.2025 г., 21:47 ч. UTC

Печалби

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22.10.2025 г., 21:47 ч. UTC

Придобивния, сливания и поглъщания

Woodside: Williams to Contribute Its Share of Capex for LNG Facility, Pipeline

22.10.2025 г., 21:46 ч. UTC

Придобивния, сливания и поглъщания

Woodside Energy Says Williams Deals Worth US$378 Million Including Capital Reimbursement

22.10.2025 г., 21:45 ч. UTC

Придобивния, сливания и поглъщания

Woodside Energy to Sell 80% Interest in Driftwood Pipeline Co. to Williams

22.10.2025 г., 21:45 ч. UTC

Придобивния, сливания и поглъщания

Woodside Energy to Sell 10% Interest in Louisiana LNG Holding Co. to Williams

22.10.2025 г., 21:28 ч. UTC

Пазарно говорене
Печалби

Correction to Alcoa Tariff Market Talk

22.10.2025 г., 21:25 ч. UTC

Печалби

Wall Street Wonders if Grail's Cancer Test Results Are a True Positive -- Barrons.com

22.10.2025 г., 21:17 ч. UTC

Печалби

Tesla Profit Plunges Despite Third-Quarter Rush to Buy EVs -- 2nd Update

22.10.2025 г., 21:09 ч. UTC

Пазарно говорене
Печалби

Alcoa Says Delivery Fee Covering Tariff Costs -- Market Talk

22.10.2025 г., 21:00 ч. UTC

Пазарно говорене

ESG Roundup: Market Talk

22.10.2025 г., 20:59 ч. UTC

Печалби

SAP Stock Drops After Earnings. Cloud Revenue Fell Short. -- Barrons.com

22.10.2025 г., 20:51 ч. UTC

Печалби

SAP Reports Mixed Earnings. The Stock is Down. -- Barrons.com

22.10.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

22.10.2025 г., 20:44 ч. UTC

Печалби

Kaiser Aluminum: For the Full Yr 2025, Now Expects Conversion Rev to Be Flat to Up 5% Yr-Over-Yr and Raises Adjusted EBITDA Outlook to Improve 20% to 25% Yr-Over-Yr >KALU

Сравнение с други в отрасъла

Ценова промяна

Vaxart Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

0

Купи

0

Задържане

0

Продай

Техническа оценка

By Trading Central

0.4007 / 0.4252Подкрепа & съпротива

Краткосрочен план

Bearish Evidence

Средносрочен план

Bearish Evidence

Дългосрочен план

Weak Bearish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Vaxart Inc

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.
help-icon Live chat